Published date: 23 September 2022
This notice was replaced on 23 September 2022
This notice does not contain the most up-to-date information about this procurement. The most recent notice is:
Opportunity (published 23 September 2022, last edited 14 October 2022)
Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.
Contract summary
Industry
Pharmaceutical products - 33600000
Location of contract
WA7 2ES
Value of contract
£37,200,000
Procurement reference
CF-1004200D0O000000rwimUAA
Published date
23 September 2022
Closing date
27 October 2022
Closing time
1pm
Contract start date
1 January 2023
Contract end date
31 December 2023
Contract type
Supply contract
Procedure type
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
NHS National Framework Agreement for the supply of Eculizumab
Offer reference number: CM/PHR/22/5659
Period of framework: 01 January 2023 to 31 December 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
More information
Attachments
-
- Document No. 02 - Terms of offer.doc
- Document No. 02 - Terms of offer
-
- Document No. 03 - Framework Agreement and Terms and Conditions..pdf
- Document No. 03 - Framework Agreement and Terms and Conditions.
-
- Document No. 06 - Form of offer.doc
- Document No. 06 - Form of offer
-
- Document No. 08 - Confidential information schedule.xls
- Document No. 08 - Confidential information schedule
-
- Document No. 01 - Invitation to offer covering letter CM_PHR_22_5659.docx
- Document No. 01 - Invitation to offer covering letter CM_PHR_22_5659
-
- Document No. 04a - Quality Assurance Process.pdf
- Document No. 04a - Quality Assurance Process
-
- Document No. 05a - Selectt Offer schedule - CM_PHR_22_5659_00.xml
- Document No. 05a - Selectt Offer schedule - CM_PHR_22_5659_00
-
- Document No. 05b - Tender Product listing and usage - CM_PHR_22_5659_00.xlsx
- Document No. 05b - Tender Product listing and usage - CM_PHR_22_5659_00
-
- Document No. 05c - Volume discounts or Additional Products Offer Schedule.xls
- Document No. 05c - Volume discounts or Additional Products Offer Schedule
-
- Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements.docx
- Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements
-
- Document No. 07a - Quality control technical sheet.doc
- Document No. 07a - Quality control technical sheet
-
- Document No. 07b - Quality Assurance Policy to support the National Contract Procurement of Licensed Medicines - Edition 5.1 September 2022.pdf
- Document No. 07b - Quality Assurance Policy to support the National Contract Procurement of Licensed Medicines - Edition 5.1 September 2022
-
- Document No. 09 - Tender Design and Instructions on completing Document 6.doc
- Document No. 09 - Tender Design and Instructions on completing Document 6
-
- Document No. 10 - Participating Authorities.xls
- Document No. 10 - Participating Authorities
About the buyer
Contact name
Katie Noonan
Address
2nd Floor Rutland House
Runcorn
WA7 2ES
GB
Share this notice